Etrumadenant
Etrumadenant (AB928) is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. Etrumadenant relieves adenosine-mediated immune suppression. Etrumadenant has immunomodulatory and antitumor activities[1][2].
Product Specifications
CAS Number
2239273-34-6
Product Name Alternative
AB928
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/etrumadenant.html
Purity
99.67
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
N#CC1=CC=CC(C2=NC(N)=NC(C3=CN(CC4=NC(C(C)(O)C)=CC=C4)N=N3)=C2)=C1C
Molecular Formula
C23H22N8O
Molecular Weight
426.47
Precautions
H315, H319, H320
References & Citations
[1]Seitz L, et al. Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers. Invest New Drugs. 2019 Aug;37 (4) :711-721.|[2]Daniel DiRenzo, et al. AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression [abstract].
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881784-500 1x 500 µL
Histone H1 (Nuclear Marker) (HH1/1784R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
1317-AAT 2 Labelings
Buccutite™ Rapid PE-Cy7 Tandem Antibody Labeling Kit *Microscale Optimized for Labeling 100 ug Antibody Per Reaction*
Sign In for Pricing
View Details 